Centaurus Financial’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2	Closed	-$11	–	482
2018 Q3	$11	Sell	2 -1,798	-100%	-$9.89K	﹤0.01%	535
2018 Q2	$14K	Buy	1,800 +133	+8%	+$1.03K	﹤0.01%	1414
2018 Q1	$58K	Hold	1,667	–	–	0.01%	450
2017 Q4	$71K	Buy	+1,667	New	+$71K	0.02%	314